Immune evasion and inhibition of T cell anti-tumor response in mouse PDA is mediated by upregulation of programmed cell death-ligand 1 (PD-L1) in tumor cells (106), but immunotherapy approaches that target PD-1 so far were not successful for this cancer. This evidence concerns the gene CD274 and neoplasm.